Krka group net down 5% in 2015 as sales stagnate

Novo Mesto, 3 March - Drug maker Krka reported a group net profit of EUR just over EUR 158m for 2015, down 5% over the year before. Revenue declined by 2% to EUR 1.16bn, despite an uptick in volume sales, according to unaudited results released on Thursday.

Novo mesto
The logo of pharma company Krka.
Photo: Rasto Božič/STA

The rest of this news item is available to subscribers.
The news item consists of 851 characters (without spaces) or 176 words words.

Buy the news item. Price: 2 tokens; on account: 0 tokens.

© STA, 2016